2 withdrawn, 1 completed. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Withdrawn 2, Completed 1 |
Follow TO Pharmaceuticals: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Investigate the Efficacy and Safety of Cannabis Oil for the Treatment of Subjects With Hidradenitis Suppurativa Cannabis oil, Placebo - Hidradenitis Suppurativa | Phase 2 | Withdrawn | TO Pharmaceuticals | 2020-09-01 | 2021-08-04 | |
| A Trial to Assess the Efficacy and Safety of Medical Grade Cannabis in Children Diagnosed With Autism Spectrum Disorder Medical Grade Cannabis oil, Placebos - Autistic Disorder | Phase 2 | Withdrawn | TO Pharmaceuticals | 2020-09-01 | 2022-06-09 | |
| The Effect of Cannabis on Dementia Related Agitation and Aggression Cannabis, Placebo oil - Agitation Related to Dementia | Phase 2 | Completed | TO Pharmaceuticals | 64 | 2017-12-07 | 2022-03-08 |
Marijuana Abuse (2) · Autistic Disorder (1) · Hidradenitis Suppurativa (1)
nabiximols (3) · Olive Oil (2) · Chlorophyll (1)
Israel (3)
Lihi Bar-LEv (1) · Vered Hermush, Dr (1)